Pulmonx Corporation, a global leader in minimally invasive treatments for severe lung disease, announces the presentation of interim results from the CONVERT Study at...
Dry reforming of methane (DRM) is a promising approach to converting methane and carbon dioxide into chemical feedstock or syngas. However, DRM needs a...
